ClinConnect ClinConnect Logo
Search / Trial NCT02778633

Mean Systemic Filling Pressure and Heart Performance Predicting Fluid Responsiveness in Sepsis

Launched by CATHARINA ZIEKENHUIS EINDHOVEN · May 19, 2016

Trial Information

Current as of May 20, 2025

Unknown status

Keywords

Volume Responsiveness Mean Systemic Filling Pressure

ClinConnect Summary

The assessment of the cardiovascular state in critically ill patients is subject to difficulties in terms of the fact that several hemodynamic parameters, for example mean arterial blood pressure (MAP) and cardiac output (CO) supply insufficient information about the circulating volume and cardiac performance. There is a clinical need to adequate determination of intravascular volume status and therefore reliable predictors of fluid responsiveness are highly relevant. However, in determining the fluid status of a patient, the lack of appreciation of the venous side of the circulation persis...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients must be older than 18 years, and must be equipped with a pulse-contour cardiac output system with a central venous catheter.
  • Patients will be subsequently connected to the hemodynamic monitoring device Navigator™.
  • In those patients with clinical signs of inadequate tissue perfusion, passive leg raising and standardized fluid challenge will be performed.
  • Exclusion Criteria:
  • Patients with assist devices (e.g. intra aortic balloon pump, Impella®, ECMO), patients with arrhythmias (either atrial of ventricular) will be excluded from the study.
  • Also, patients with inguinal impairment or contraindications for a passive leg raising will be excluded (such as deep venous thrombosis or elastic compression stocking), head trauma, an increase intra-abdominal pressure suspected by clinical context and examination as well as patients with absolute contraindications for fluid challenge.

About Catharina Ziekenhuis Eindhoven

Catharina Ziekenhuis Eindhoven is a leading healthcare institution in the Netherlands, dedicated to delivering high-quality patient care and advancing medical research. As a prominent clinical trial sponsor, the hospital is committed to facilitating innovative research initiatives that aim to improve treatment outcomes and enhance patient quality of life. With a diverse range of medical specialties and a collaborative approach, Catharina Ziekenhuis Eindhoven fosters an environment that supports rigorous clinical trials, ensuring adherence to ethical standards and regulatory guidelines while prioritizing patient safety and well-being. Through its robust infrastructure and expertise, the hospital actively contributes to the development of new therapies and medical technologies, playing a vital role in the evolution of healthcare.

Locations

Eindhoven, North Brabant, Netherlands

Patients applied

0 patients applied

Trial Officials

Jan Bakker, MD, PhD

Study Chair

Erasmus Medical Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials